Imagion Biosystems Limited (IBXXF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Nov 25, 2025
Imagion Biosystems Revenue
Imagion Biosystems had revenue of 25.73K AUD in the half year ending June 30, 2025, a decrease of -96.27%. This brings the company's revenue in the last twelve months to 1.06M, down -82.15% year-over-year. In the year 2024, Imagion Biosystems had annual revenue of 2.67M, down -46.38%.
Revenue (ttm)
1.06M AUD
Revenue Growth
-82.15%
P/S Ratio
12.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.35M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.67M | -2.31M | -46.38% |
| Dec 31, 2023 | 4.97M | 1.90M | 61.87% |
| Dec 31, 2022 | 3.07M | 215.36K | 7.54% |
| Dec 31, 2021 | 2.86M | 158.60K | 5.88% |
| Dec 31, 2020 | 2.70M | 206.96K | 8.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Interpace Biosciences | 41.92M |
| Psychemedics | 19.69M |
| China New Energy Group Company | 12.51M |
| Aspira Women's Health | 9.34M |
| Longduoduo Company | 4.15M |
| IDenta | 1.24M |
Imagion Biosystems News
- 9 days ago - Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent - Business Wire